A Prospective Randomized Trial of Capecitabine Treatment in Patients With HNSCC
Clinical trial NCT03678649 · UNKNOWN
Trial details
- NCT number
- NCT03678649
- Sponsor
- Zhejiang Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-10
- Primary completion
- 2020-12-30
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.